- Home
- BNTX vs DXCM Comparison
BNTX vs DXCM Comparison
Compare BNTX & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- DXCM
- Stock Information
- Founded
- BNTX 2008
- DXCM 1999
- Country
- BNTX Germany
- DXCM United States
- Employees
- BNTX N/A
- DXCM N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- DXCM Medical/Dental Instruments
- Sector
- BNTX Health Care
- DXCM Health Care
- Exchange
- BNTX Nasdaq
- DXCM Nasdaq
- Market Cap
- BNTX 23.9B
- DXCM 28.0B
- IPO Year
- BNTX 2019
- DXCM 2005
- Fundamental
- Price
- BNTX $114.13
- DXCM $80.24
- Analyst Decision
- BNTX Strong Buy
- DXCM Buy
- Analyst Count
- BNTX 15
- DXCM 17
- Target Price
- BNTX $143.50
- DXCM $98.00
- AVG Volume (30 Days)
- BNTX 659.5K
- DXCM 3.4M
- Earning Date
- BNTX 11-04-2024
- DXCM 02-06-2025
- Dividend Yield
- BNTX N/A
- DXCM N/A
- EPS Growth
- BNTX N/A
- DXCM 83.21
- EPS
- BNTX N/A
- DXCM 1.67
- Revenue
- BNTX $3,390,698,192.00
- DXCM $3,954,000,000.00
- Revenue This Year
- BNTX N/A
- DXCM $13.10
- Revenue Next Year
- BNTX N/A
- DXCM $14.74
- P/E Ratio
- BNTX N/A
- DXCM $48.12
- Revenue Growth
- BNTX N/A
- DXCM 16.19
- 52 Week Low
- BNTX $76.53
- DXCM $62.34
- 52 Week High
- BNTX $131.49
- DXCM $142.00
- Technical
- Relative Strength Index (RSI)
- BNTX 49.15
- DXCM 58.78
- Support Level
- BNTX $109.52
- DXCM $74.50
- Resistance Level
- BNTX $115.34
- DXCM $81.51
- Average True Range (ATR)
- BNTX 4.74
- DXCM 2.57
- MACD
- BNTX -0.80
- DXCM -0.10
- Stochastic Oscillator
- BNTX 29.03
- DXCM 81.88
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.